Vigabatrin Tablet, Film Coated
Product Images NDC 0591-3851

4 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 0591-3851). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure of vigabatrin showing its molecular arrangement with amino, vinyl, and carboxylic acid functional groups.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A line graph showing cumulative percentage of patients versus percentage reduction in seizure frequency. The graph compares placebo and three dosage levels of Vigabatrin (1g/day, 3g/day, 6g/day), illustrating seizure frequency improvement or worsening among patients.*
FDA Label Image

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Image 3)

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Image 3)
A line graph depicting the percentage reduction in seizure frequency versus percentage of patients. It compares placebo with Vigabatrin 3g/day showing trends of improvement or worsening in seizure frequency.*
FDA Label Image

1 (Image 4)

1 (Image 4)
Label for Vigabatrin Tablets, USP, 500 mg, film-coated tablets by Actavis Pharma, Inc. The label indicates a package count of 100 tablets with storage and dispensing instructions. Manufactured in India by Watson Pharma Private Limited for Teva Pharmaceuticals USA, Inc. The NDC code shown is 0591-3851-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.